Tagged Articles

artificial hip 231 articles

DePuy seeks to overturn $8.26 million jury award in first ASR hip trial

Johnson & Johnson and its orthopedics unit DePuy seek to overturn a Los Angeles jury’s decision to award $8.26 million to a plaintiff for injuries he received from a metal-on-metal DePuy ASR hip implant. The companies claim that the jury’s findings were inconsistent with court instructions about defective product design and adequate warning of the device’s risk. The verdict DePuy and its parent company want to overturn concluded the first U.S. trial involving defective ASR hip implants. Plaintiff Loren Kransky sued DePuy and affiliated companies after the ASR device he had implanted in his left hip in 2007 failed and ... Read More

Unexplained pain in patients with metal hip implants should be addressed promptly

Patients with failing metal-on-metal hip implants often complain of pain. New research shows the pain these patients are experiencing may be caused by tissue damage and not by wear of the implant. Traditional hip implants are made of ceramic or plastic parts, but a newer generation of hip implants introduced a decade ago featured an all-metal design. These metal-on-metal implants have recently been shown to fail at a higher than expected rate. The failures appear to be accelerated by the leeching of metal ions from the devices into surrounding tissue, causing tissue damage. The ions have also been found to ... Read More

Researchers unsure how to evaluate metal ion levels in patients with metal-on-metal hip implants

Blood tests to measure the amount of metal ions in the blood of patients with metal-on-metal hip implants are inexpensive and provide helpful information. But they do not provide definitive information whether an artificial hip is functioning poorly and is likely to fail, new research shows. Chromium and cobalt ion levels are generally elevated in the blood of patients with all-metal hip implants. Because the implants have been found more likely to fail than traditional hip implants, medical regulators say that patients with the devices should be monitored on a regular basis for signs of failure. That monitoring generally includes a ... Read More

Designer of metal hip implant says he no longer uses the defective devices

Dr. Thomas Schmalzried, an orthopedic surgeon and one of the lead designers of the ASR metal-on-metal hip replacement system made by Johnson & Johnson subsidiary DePuy Orthopaedics, testified before a jury this week that he would not implant the device in patients today. Schmalzied made the statement while testifying at the second trial involving the DePuy all-metal hip implants, which have since been taken off the market. An estimated 93,000 people worldwide received the DePuy ASR hip implant when they were recalled in 2010. Johnson & Johnson and DePuy face more than 10,000 lawsuits from patients who say they were ... Read More

DePuy’s ASR hip implant caused plaintiff’s bone decay, surgeon tells jury

An orthopedic surgeon testifying on behalf of a woman who alleges she was injured by ASR metal hip implants manufactured by DePuy Orthopedics told jurors in the Circuit Court of Cook County, Illinois, that metal debris from the hip devices “absolutely” caused the plaintiff to suffer from bone decay. DePuy is a subsidiary of Johnson & Johnson. Surgeon Tony Nargol, who has warned about the dangers of metal-on-metal hip implants such as DePuy’s ASR devices, particularly to women, told jurors that plaintiff Carol Strum’s calcar bone had been “eaten away” near the ASR hip device she had implanted in in ... Read More

DePuy’s tests on metal artificial hip system failed to show potential dangers of device

Orthopedic doctors were optimistic when metal-on-metal hip replacement systems were first introduced around the world. They offered a seemingly more durable alternative to traditional ceramic or plastic artificial hips. The devices were especially attractive to younger recipients, who wanted to go back to a more active lifestyle. DePuy Orthopaedics, a subsidiary of Johnson & Johnson, introduced the DePuy ASR metal-on-metal hip replacement system and hip resurfacing system. The hip replacement system was quickly approved in the United States without prior human testing because it was similar to devices already on the market. However, the Food and Drug Administration (FDA) refused to ... Read More

Johnson and Johnson lowers bonuses for top executives after ‘disappointing’ year

Johnson & Johnson is lowering planned bonuses for its CEO and other top executives because the year has been plagued with “disappointments,” including continued product recalls, slow sales growth, and a tarnished public image. Despite the bonus discounts, CEO Alex Gorsky pocketed $8.93 million in total compensation for 2012, an increase of more than 60 percent from the $5.52 million he received in 2011. Gorksy was promoted from vice chairman of the company to chief executive last April and became chairman in December. His predecessor, Bill Weldon, received total compensation of more than $26 million in 2012 – more than ... Read More

Montana man awarded $8.3 million in first of 10,000+ DePuy metal hip implant lawsuits

Johnson & Johnson subsidiary DePuy Orthopaedics designed a flawed metal-on-metal hip replacement system and owes a retired prison guard from Montana $8.3 million in compensatory damages, a California jury decided in the first of more than 10,000 lawsuits regarding the devices to stand trial. Loren “Bill” Kransky sued DePuy arguing that the company failed to adequately test the device before marketing it in the United States. His lawsuit also claims the company covered up surgeon complaints of failures and considered redesigning the ASR model before ultimately deciding to stop making it in 2008. Johnson & Johnson recalled 93,000 DePuy ASR ... Read More

Johnson & Johnson ordered to pay $8.3 million in first hip implant lawsuit to go to trial

A Los Angeles jury found in favor of Plaintiff Loren “Bill” Kransky, ordering Johnson & Johnson to pay the man $8.3 million in compensatory damages for debilitating injuries he suffered as a result of a faulty hip implant. This was the first of many cases pending in ongoing litigation against J&J and its subsidiary, DePuy orthopedics, involving the ASR XL metal-on-metal hip implant. Court documents unsealed before the trial started showed that DePuy executives knew in 2008 that the ASR hip implants were failing early at unusually high rates, but the company continued to make the devices for several more ... Read More

DePuy estimated more than a third of its metal hips would fail after less than five years

A year after DePuy Orthopaedics recalled 93,000 artificial hips from around the world, the company estimated that more than a third of the devices would fail within four and a half years, according to the company’s internal documents recently unsealed as part of court records. The evidence was revealed during the first of more than 10,000 lawsuits against DePuy and Johnson & Johnson regarding the defective hip implants, and has caused a wave of concern halfway around the world, with British MPs calling for a criminal inquiry into DePuy based on the unsealed documents. The failure-rate estimate came during pretrial ... Read More